🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

Amazon, Progress Software And 2 Other Stocks Insiders Are Selling

Published 12/02/2024, 13:19
Updated 12/02/2024, 14:40
© Reuters.  Amazon, Progress Software And 2 Other Stocks Insiders Are Selling
AMZN
-
AMP
-
PRGS
-
VKTX
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

The Nasdaq 100 closed higher by 1% on Friday. Investors, meanwhile, focused on some notable insider trades.

When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company’s prospects or that they view the stock as being overpriced. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.

Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.

Amazon.com

  • The Trade: Amazon.com, Inc. (NASDAQ: AMZN) Executive Chair Jeffrey P Bezos sold a total of 11,997,698 shares at an average price of $170.21. The insider received over $2 billion from selling those shares. The company’s CEO Worldwide Amazon Stores also sold 20,200 shares.
  • What’s Happening: Amazon.com announced that it will lay off hundreds of employees at its One Medical and Pharmacy units as part of a major cost-cutting initiative.
  • What Amazon.com Does: Amazon is a leading online retailer and one of the highest-grossing e-commerce aggregators, with $386 billion in net sales and approximately $578 billion in estimated physical/digital online gross merchandise volume in 2021.
Have a look at our premarket coverage here

Viking Therapeutics

  • The Trade: Viking Therapeutics, Inc. (NASDAQ: VKTX) President and CEO Brian Lian sold a total of 45,000 at an average price of $29.90. The insider received around $1,345,500 from selling those shares.
  • What’s Happening: Viking Therapeutics posted in-line loss for its fourth quarter.
  • What Viking Therapeutics Does: Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders.
Ameriprise Financial
  • The Trade: Ameriprise Financial, Inc. (NYSE: AMP) Executive VP and CFO Walter Stanley Berman sold a total of 13,346 shares at an average price of $387.81. The insider received around $5,175,664 from selling those shares.
  • What’s Happening: Ameriprise Financial reported better-than-expected fourth-quarter financial results.
  • What Ameriprise Financial Does: Ameriprise Financial has emerged is a major player in the U.S. market for asset and wealth management, with around $1.3 trillion in total assets under management and advisement at the end of the second quarter of 2023.
Progress Software
  • The Trade: Progress Software Corporation (NASDAQ: PRGS) EVP/GM Infrastructure Mgmt Sundar Subramanian sold a total of 2,475 shares at an average price of $57.38. The insider received around $142,016 from selling those shares.
  • What’s Happening: Progress Software posted stronger-than-expected results for its fourth quarter.
  • What Progress Software Does: Progress Software Corporation is a provider of cloud-based security solutions to large-and mid-sized organizations in a wide range of industries.

Check This Out: Jim Cramer Looks At Blackstone, Praises MercadoLibre: 'They're Incredibly Smart'

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.